Horizon Therapeutics plc provided earnings guidance for the full year 2022. For the year, the company expects net sales to range between $3.9 billion and $4.0 billion, representing 22% growth at the midpoint.
Horizon Therapeutics Public Limited Company
Equities
HZNP
IE00BQPVQZ61
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+54.61% | 811B | |
+43.70% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+17.94% | 246B | |
+2.66% | 225B | |
+12.77% | 218B | |
+8.61% | 168B |